there could be a breakthrough in the way we treat covid 19. interim trials suggest a new, experimental drug could cut the risk of hospitalisation, or death, by about half. if authorised by regulators, the treatment will be the first oral, antiviral medication for covid 19. mark lobel reports. this is the first covid pill. trial results suggest it can cut hospitalisations or deaths by half. the news of the efficacy of this particular antiviral is obviously very good news. the company, when they briefed us last night, had mentioned that they will be submitting their data to the fda imminently. the data are impressive. pills were given to 775 unvaccinated, elderly or medically at risk volunteers within five days of them showing coronaviruses symptoms. the data from a phase three trial
be submitting their data to the fda imminently. the be submitting their data to the fda imminentl . ., ., be submitting their data to the fda imminentl . :, ., ., be submitting their data to the fda imminentl . :, :, ., , , , imminently. the data are impressive. pills were given imminently. the data are impressive. pills were given to imminently. the data are impressive. pills were given to 775 pills were given to 775 unvaccinated, medically at risk volunteers within five days of them showing coronaviruses symptoms. the data from a phase three trial showed 7.3% of patients on the drug were hospitalised compared to 14.1% of those who didn t take the tablets. eight patients who were given a placebo or dummy pill later died of covid 19, but there were no deaths in the group taking the pill. the trial was stopped early because the pill was so successful. but data still needs to be peer reviewed. so how does it work? as corona virus replicates itself inside your body, these antiviral
or deaths by half. the news of the efficacy of this particular antiviral is obviously very good news. the company, when they briefed us last night, had mentioned that they will be submitting their data to the fda imminently. the data are impressive. pills were given to 775 elderly or medically at risk patients within five days of them showing coronavirus symptoms. the data from a phase three trial showed 7.3% of patients on the drug were hospitalised, compared to 14.1% of those who did not take the tablets. eight patients who were given a placebo or dummy pill later died of covid, but there were no deaths in the group taking the pill. the trial was stopped early because the pill was so successful. the data still needs to be peer reviewed.
the news of the efficacy of this particular antiviral is obviously very good news. the company, when they briefed us last night, had mentioned that they will be submitting their data to the fda imminently. the data are impressive. pills were given to 775 elderly or medically at risk patients within five days of them showing coronavirus symptoms. the data from a phase three trial showed 7.3% of patients on the drug were hospitalised, compared to 14.1% of those who did not take the tablets. eight patients who were given a placebo or dummy pill later died of covid, but there were no deaths in the group taking the pill. the trial was stopped early because the pill was so successful. the data still needs to be peer reviewed. so how does it work? as coronavirus replicates itself inside your body, these antiviral pills trick it into using the drug, which then inserts errors into the virus s genetic code,
hospitalisations by death might have. , ., , ., have. the news of the efficacy of this particular have. the news of the efficacy of this particular antiviral have. the news of the efficacy of this particular antiviral is - this particular antiviral is obviously particularly good news was at the company, when they briefed us last night had they will be submitting their data to the fda imminently. the data are impressive. pills were given to 775 unvaccinated elderly or medically at risk volunteers within five days of them showing corona virus symptoms. the data from a phase three trial showed 7.3% of patients on the drug were hospitalised compared to 14.1% those who did not take tablets. eight patients were given a placebo later dies of covert but there were no deaths in the group taking the pill. the trial was stopped early because the pill was so successful. the data still needs to be peer reviewed. so how does it work? as coronavirus replicates itself inside your body these antivi